Page last updated: 2024-11-04

temozolomide and Pituitary Diseases

temozolomide has been researched along with Pituitary Diseases in 1 studies

Pituitary Diseases: Disorders involving either the ADENOHYPOPHYSIS or the NEUROHYPOPHYSIS. These diseases usually manifest as hypersecretion or hyposecretion of PITUITARY HORMONES. Neoplastic pituitary masses can also cause compression of the OPTIC CHIASM and other adjacent structures.

Research Excerpts

ExcerptRelevanceReference
"Pre-temozolomide treatment, these data were 5."1.91Efficacy and safety of temozolomide in the treatment of aggressive pituitary neuroendocrine tumours in Spain. ( Araujo-Castro, M; Biagetti, B; Cámara, R; Fajardo, C; García-Centeno, R; Guerrero-Pérez, F; Hanzu, F; Iglesias, P; Lamas, C; Mora, M; Remon-Ruiz, P; Soto, A, 2023)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Lamas, C1
Cámara, R1
Fajardo, C1
Remon-Ruiz, P1
Biagetti, B1
Guerrero-Pérez, F1
Araujo-Castro, M1
Mora, M1
Hanzu, F1
Iglesias, P1
García-Centeno, R1
Soto, A1

Other Studies

1 other study available for temozolomide and Pituitary Diseases

ArticleYear
Efficacy and safety of temozolomide in the treatment of aggressive pituitary neuroendocrine tumours in Spain.
    Frontiers in endocrinology, 2023, Volume: 14

    Topics: Female; Humans; Male; Neuroendocrine Tumors; Pituitary Diseases; Pituitary Neoplasms; Retrospective

2023